Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CTIX.2.08 and uplisting. Long term looks great
About Cellceutix:
Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol "CTIX". Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix's anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the "Guardian Angel Gene" due to its crucial role in controlling cell mutations. Cellceutix has submitted an IND to the FDA for its planned Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix's anti-psoriasis drug Prurisol has recently completed a Phase 1 clinical trial and is being readied for a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix's key antibiotic, Brilacidin, has completed enrollment in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than most currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site at www.cellceutix.com.
CTIX. 2.08. Monster in the making. Long term
About Cellceutix:
Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol "CTIX". Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix's anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the "Guardian Angel Gene" due to its crucial role in controlling cell mutations. Cellceutix has submitted an IND to the FDA for its planned Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix's anti-psoriasis drug Prurisol has recently completed a Phase 1 clinical trial and is being readied for a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix's key antibiotic, Brilacidin, has completed enrollment in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than most currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site at www.cellceutix.com.
CTIX. Real as it gets. http://cellceutix.com/pipeline/#sthash.bW9sEbtB.dpbs
CTIX. 2.08 do the DD.http://cellceutix.com/pipeline/#sthash.bW9sEbtB.dpbs
Do the DD on CTIX. 2.08 for now.http://cellceutix.com/pipeline/#sthash.bW9sEbtB.dpbs
CTIX. 2.08 ready for breakout.
CTIX. 2.07 Might take 2 years for 10 bagger but it is real.
http://cellceutix.com/pipeline/#sthash.bW9sEbtB.dpbs
CTIX hitting yearly high. Long term hold. Do your due diligence.
CTIX,a long term hold. Do your DD
http://cellceutix.com/pipeline/#sthash.bW9sEbtB.dpbs
CTIX, ....eom
CTIX..eom
Testing..eom
I will take my guess a step future
The World Health Organization started the experimental antibiotic trials 3-4 weeks ago . There was no cures and they realized the situation was getting out of control. That is why they decided to let drugs in various stage trials to be tested on humans in this condition.
This is where my theory gets wild.
B was a part of this early testing . B had a impressive outcome. Impressive enough for someone associated with the trials to order 66 pounds of B . That is basically 500,000 doses ordered at the same time a deadly disease with no cure is spreading out of control.
I hope my theory is right. CTIX will get fast track immediately and World wide attention.
I believe longs would be financially happy.
GLTA
I believe the significant development regarding B ?
It was selected as one of the experimental drugs by the World Health Organization to be used against the deadly Ebola outbreak. They are now using different drugs that are in various clinical stages to try stopping the spread of this plague.
That is my guess.
Have great weekend
First, I want to apologize for the inaccuracies about the news story I seen the other day. It won't happen again as I will look at the time on the clock and the channel I am watching. I am a major channel flipper. I will put my hand on a bible about what the gentleman from Dana Farber stated in the interview. He was asked if there was any exciting developments happening in cancer research. He stated that they were seeing very impressive results involving lung, head and neck, and solid tumors. He believed that it was the future of cancer remedies because it was NON TOXIC. He NEVER mentioned any company or compound name that was being used in their study. He also said that he expects whatever they were using to be approved and on the market within 18 to 24 months. He was that confident with the results he was seeing.
It sounded to me like K or another product similar to K that are in related trials. Personally I don't know if K can be ready in that time period. I will leave that question to those who are much more knowledgeable if all went well for K in future trials.
Enough said, have a great weekend to all.
There was a cancer researcher from Dana Farber on CNBC during the afternoon 2 days ago stating that they are testing a couple of items that were showing impressive results. He said the trails were involving solid tumors, lung cancer, head and neck cancer and a few others. His description was molecular compounds with no toxic effects on the body. He believed that this was the future in treating cancer but it was going to be 18-24 months before it would be on the market. It sure sounded like he was speaking about K.
I believe the updates on K will be excellent.
GLTA
Probably.
I hope my children enjoy the 10000 shares I left them each .Goodbye to all
I am the only one buying today. 11000 at 2.04. Eom
Great post..eom
Yep, it's over. Move on.EOM
They will go to the bigger boards when they do another R/S. 20000/1 is my guess. Then take a serious SHORT position.
He will be one wealthy individual, good for him and his family. He can now enjoy his family and the other interest's in his life basically without restrictions. He will just do it much quicker than the rest of the longs. Good for him, our day will come.
GLTA.
By far, I consider the CTIX board the best board on IHUB.
The information gathered here is extremely valuable. Multiple great posters and moderators that keep the nonsense at a minimum.
BTW, all longs are going to be wealthy beyond belief.
Have a great weekend.
I hope you are right. That would be awesome for shareholders.EOM
The Phase 2 results will be good. Connect the dots. Phase 2 near a end-Leo talking with big pharmacy company on transfer agreement- Massive 66 pounds of B being produced right now. I think the big pharma is getting this huge haul for their own testing and if all goes right CTIX is on their way to the BIG time.
Have a great day.
My Ameritrade account shows 619,309 shares traded. eom
9/18 PR states they are producing 30 kg of product ? .eom
Nice mention in article. Thanks...eom
Nice volume, even some pre market...eom
A/S goes from 30 million to 700 million in less than a week after a 100-1 reverse split. Only one reason to do that move. A year from now they will have it raised to 3 billion again and the cycle will start all over once again. Plutus and jeagerboy have these guys pegged.
I say they are already diluting. Too much volume...eom
Since June 2008 they have increased the O/S only 16 million shares. That is a incredible statement in the OTC market. That is management looking out for the people investing in their company.
There must be something good happening behind the curtain if they are talking about uplisting. I believe you have to trade at a price above 4 $ for 90 days for the NASDAQ and 4$ for the NYSE. It would take some good news at this point to accomplish that goal.
Go CTIX
Thank you all. So informative . c ya at 100 a share. Eom
This is by far the BEST board on this pathetic website ...eom
They can change the A/S any time they want too.
You are absolutely correct. Death spiral financing. The institution will do great at the expense of shareholders.
I was addressing a TGTBT Spam..eom